...
首页> 外文期刊>Saudi Journal of Biological Sciences >Scintigraphy has the potential to replace thyroid stimulating hormone and ultrasonography in hyperthyroidism diagnosis
【24h】

Scintigraphy has the potential to replace thyroid stimulating hormone and ultrasonography in hyperthyroidism diagnosis

机译:闪烁的方法有可能取代甲状腺激素和超声检查在甲状腺功能亢进诊断中

获取原文

摘要

The value of thyroid scintigraphy in hyperthyroidism diagnosis has long been the subject of debate. Unresolved issue is whether scintigraphy should be performed routinely, selectively, or for all hyperthyroidism patients. So, this study is concerned with the evaluation of thyroid scintigraphy for identifying hyperthyroidism in comparison with thyroid stimulating hormone (TSH) and ultrasound. This is cross sectional study including convenient patients sample (n?=?50, 15 males and 35 females) aged (20–50?years) with primary hyperthyroidism and were attending endocrine clinics at King Faisal Specialist Hospital and Research Centre. All patients performed clinical investigations (TSH, ultrasound and thyroid scintigraphy). Among these patients, 96%, 48/50, had positive findings for hyperthyroidism with thyroid SC (95% CI; 96.0–99.5%); 84%, 42/50, had positive findings for hyperthyroidism by US (95% CI; 70.9–92.8%); and 56%, 28/50, had positive findings for hyperthyroidism by TSH measurement (95% CI; 41.3.0–70.0%). There was very good agreement between scintigraphy diagnosis and ultrasonography (kappa score?=?0.812 ( P ?0.0001), 95% CI (0.77–0.85). In many cases, scintigraphy provides considerably more functioning and anatomic details than ultrasound. In conclusion, these findings bring forth practical aspects of thyroid scintigraphy utilization for hyperthyroidism. By combining functional and anatomical information in one step, scintigraphy provides non-invasive, simple, fast and cost effective hyperthyroidism diagnostic method and has the potential to replace TSH and ultrasonography in hyperthyroidism investigation.
机译:甲状腺透明度在甲状腺功能亢进诊断中的价值长期以来一直是辩论的主题。未解决的问题是闪烁扫描是否应常规,有选择性地或所有甲状腺功能亢进患者进行。因此,该研究涉及与甲状腺刺激激素(TSH)和超声波相比,评估甲状腺闪烁术中鉴定甲状腺功能亢进。这是横截面研究,包括方便患者样本(N?= 50,15岁及35名女性),患有原发性甲状腺功能亢进,并在王代理专业医院和研究中心参加内分泌诊所。所有患者均进行临床调查(TSH,超声波和甲状腺闪烁扫描)。在这些患者中,96%,48/50,对甲状腺激素具有阳性结果(95%CI; 96.0-99.5%); 84%,42/50,对美国的甲状腺功能亢进有阳性结果(95%CI; 70.9-92.8%);和56%,28/50,TSH测量有甲状腺功能亢进的阳性发现(95%CI; 41.3.0-70.0%)。闪烁的诊断和超声检查之间存在非常良好的一致性(Kappa得分?= 0.812(p <0.0001),95%CI(0.77-0.85)。在许多情况下,闪烁的方式提供比超声波的更多功能和解剖细节。总之这些发现引发了甲状腺闪烁利用的实际方面,对甲状腺功能亢进症的使用。通过结合函数和解剖信息在一步中,闪烁症提供无侵袭性,简单,快速,成本效果的甲状腺功能亢进诊断方法,并且有可能在甲状腺功能亢进中取代TSH和超声检查调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号